- Home
- RCEL vs MPA Comparison
RCEL vs MPA Comparison
Compare RCEL & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- MPA
- Stock Information
- Founded
- RCEL N/A
- MPA 1992
- Country
- RCEL United States
- MPA United States
- Employees
- RCEL N/A
- MPA N/A
- Industry
- RCEL Medical/Dental Instruments
- MPA Finance Companies
- Sector
- RCEL Health Care
- MPA Finance
- Exchange
- RCEL Nasdaq
- MPA Nasdaq
- Market Cap
- RCEL 140.5M
- MPA 140.1M
- IPO Year
- RCEL N/A
- MPA N/A
- Fundamental
- Price
- RCEL $5.54
- MPA $11.33
- Analyst Decision
- RCEL Strong Buy
- MPA
- Analyst Count
- RCEL 4
- MPA 0
- Target Price
- RCEL $13.75
- MPA N/A
- AVG Volume (30 Days)
- RCEL 1.3M
- MPA 25.2K
- Earning Date
- RCEL 11-06-2025
- MPA 01-01-0001
- Dividend Yield
- RCEL N/A
- MPA 3.83%
- EPS Growth
- RCEL N/A
- MPA N/A
- EPS
- RCEL N/A
- MPA N/A
- Revenue
- RCEL $74,884,000.00
- MPA N/A
- Revenue This Year
- RCEL $22.92
- MPA N/A
- Revenue Next Year
- RCEL $37.07
- MPA N/A
- P/E Ratio
- RCEL N/A
- MPA N/A
- Revenue Growth
- RCEL 38.32
- MPA N/A
- 52 Week Low
- RCEL $3.60
- MPA $9.87
- 52 Week High
- RCEL $14.16
- MPA $12.21
- Technical
- Relative Strength Index (RSI)
- RCEL 54.84
- MPA 58.36
- Support Level
- RCEL $5.03
- MPA $11.23
- Resistance Level
- RCEL $5.61
- MPA $11.49
- Average True Range (ATR)
- RCEL 0.39
- MPA 0.13
- MACD
- RCEL 0.00
- MPA -0.02
- Stochastic Oscillator
- RCEL 34.69
- MPA 42.86
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About MPA Blackrock MuniYield Pennsylvania Quality Fund
Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal and Pennsylvania income taxes as is consistent with its investment policies and prudent investment management.